{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T01:24:28Z","timestamp":1790645068223,"version":"4.1.0"},"reference-count":35,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,11]],"date-time":"2023-01-11T00:00:00Z","timestamp":1673395200000},"content-version":"vor","delay-in-days":1137,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["mp.uscap.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Modern Pathology"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1038\/s41379-019-0325-6","type":"journal-article","created":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T08:02:33Z","timestamp":1564646553000},"page":"1712-1726","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":39,"title":["Myeloid neoplasms in the setting of sickle cell disease: an intrinsic association with the underlying condition rather than a coincidence; report of 4 cases and review of the literature"],"prefix":"10.1016","volume":"32","author":[{"given":"Yang","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jake","family":"Maule","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jadee L.","family":"Neff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chad M.","family":"McCall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Rapisardo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anand S.","family":"Lagoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lian-He","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Regina D.","family":"Crawford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Endi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1038\/s41379-019-0325-6_bib1","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1056\/NEJMra1510865","article-title":"Sickle cell disease","volume":"376","author":"Piel","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1038\/s41379-019-0325-6_bib2","doi-asserted-by":"crossref","first-page":"18010","DOI":"10.1038\/nrdp.2018.10","article-title":"Sickle cell disease","volume":"4","author":"Kato","year":"2018","journal-title":"Nat Rev Dis Prim"},{"key":"10.1038\/s41379-019-0325-6_bib3","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1182\/blood-2016-10-745711","article-title":"Sickle cell disease: an international survey of results of HLA-identical sibling hematopoietic stem cell transplantation","volume":"129","author":"Gluckman","year":"2017","journal-title":"Blood"},{"key":"10.1038\/s41379-019-0325-6_bib4","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1111\/bjh.14167","article-title":"Haematopoietic stem cell transplantation for sickle cell disease \u2013 current practice and new approaches","volume":"174","author":"Arnold","year":"2016","journal-title":"Br J Haematol"},{"key":"10.1038\/s41379-019-0325-6_bib5","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.bbmt.2017.01.009","volume":"23","author":"Shenoy","year":"2017","journal-title":"Biol Blood Marrow Transpl"},{"key":"10.1038\/s41379-019-0325-6_bib6","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1177\/0141076816651037","article-title":"Risk of individual malignant neoplasms in patients with sickle cell disease: English national record linkage study","volume":"109","author":"Seminog","year":"2016","journal-title":"J R Soc Med"},{"key":"10.1038\/s41379-019-0325-6_bib7","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1182\/blood-2017-05-783233","article-title":"Increased risk of leukemia among sickle cell disease patients in California","volume":"130","author":"Brunson","year":"2017","journal-title":"Blood"},{"key":"10.1038\/s41379-019-0325-6_bib8","series-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. revised","first-page":"111","article-title":"Myelodysplastic syndrome with multilineage dysplasia","author":"Brunning","year":"2017"},{"key":"10.1038\/s41379-019-0325-6_bib9","series-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. revised","first-page":"95","article-title":"Myelodysplastic\/mueloproliferative neoplasm, unclassifiable","author":"Orazi","year":"2017"},{"key":"10.1038\/s41379-019-0325-6_bib10","series-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. revised","first-page":"82","article-title":"Chronic myelomonocytic leukaemia","author":"Orazi","year":"2017"},{"key":"10.1038\/s41379-019-0325-6_bib11","series-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. revised","first-page":"150","article-title":"Acute myeloid leukaemia with myelodysplasia-related changes","author":"Arber","year":"2017"},{"key":"10.1038\/s41379-019-0325-6_bib12","doi-asserted-by":"crossref","first-page":"E131","DOI":"10.1002\/ajh.24010","article-title":"Myelodysplastic syndrome with clonal cytogenetic abnormalities followed by fatal erythroid leukemia after 14 years of exposure to hydroxyurea for sickle cell anemia","volume":"90","author":"Aumont","year":"2015","journal-title":"Am J Hematol"},{"key":"10.1038\/s41379-019-0325-6_bib13","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1002\/ajh.23768","article-title":"Peripheral blood features of acute myeloid leukemia with myelodysplasia-related changes developing in a patient with sickle cell anemia","volume":"89","author":"Zemenides","year":"2014","journal-title":"Am J Hematol"},{"key":"10.1038\/s41379-019-0325-6_bib14","doi-asserted-by":"crossref","first-page":"925","DOI":"10.7326\/0003-4819-133-11-200012050-00029","article-title":"Acute leukemia in a patient with sickle-cell anemia treated with hydroxyurea","volume":"133","author":"Wilson","year":"2000","journal-title":"Ann Intern Med"},{"key":"10.1038\/s41379-019-0325-6_bib15","doi-asserted-by":"crossref","first-page":"149","DOI":"10.4137\/CMO.S8810","article-title":"Development of myelodysplastic syndrome and acute myeloid leukemia 15 years after hydroxyurea use in a patient with sickle cell anemia","volume":"6","author":"Baz","year":"2012","journal-title":"Clin Med Insights Oncol"},{"key":"10.1038\/s41379-019-0325-6_bib16","doi-asserted-by":"crossref","first-page":"722","DOI":"10.7326\/0003-4819-155-10-201111150-00024","article-title":"Therapy-related acute myelogenous leukemia in a hydroxyurea-treated patient with sickle cell anemia","volume":"155","author":"Taylor","year":"2011","journal-title":"Ann Intern Med"},{"key":"10.1038\/s41379-019-0325-6_bib17","doi-asserted-by":"crossref","first-page":"423","DOI":"10.5858\/2005-129-423-CMLISC","article-title":"Chronic myelogenous leukemia in sickle cell anemia","volume":"129","author":"Chen","year":"2005","journal-title":"Arch Pathol Lab Med"},{"key":"10.1038\/s41379-019-0325-6_bib18","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1097\/MAJ.0000000000000228","article-title":"Effectiveness of imatinib therapy for sickle cell sanemia and chronic myeloid leukemia","volume":"347","author":"Murphy","year":"2014","journal-title":"Am J Med Sci"},{"key":"10.1038\/s41379-019-0325-6_bib19","doi-asserted-by":"crossref","first-page":"597","DOI":"10.4103\/0377-4929.85107","article-title":"Chronic myelogenous leukemia in sickle cell\/beta 0 -thalassemia","volume":"54","author":"Sallam","year":"2011","journal-title":"Indian J Pathol Microbiol"},{"key":"10.1038\/s41379-019-0325-6_bib20","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1111\/j.1365-2141.2011.08670.x","article-title":"Chronic myeloid leukaemia and sickle cell disease: could imatinib prevent vaso-occlusive crisis?","volume":"155","author":"Stankovic Stojanovic","year":"2011","journal-title":"Br J Haematol"},{"key":"10.1038\/s41379-019-0325-6_bib21","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1080\/10428194.2017.1324158","article-title":"Accelerated leukemic transformation after haplo-identical transplantation for hydroxyurea-treated sickle cell disease","volume":"59","author":"Janakiram","year":"2018","journal-title":"Leuk Lymphoma"},{"key":"10.1038\/s41379-019-0325-6_bib22","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1002\/ajh.2830210212","article-title":"Hematologic malignancy in sickle cell disease: Report of four cases and review of the literature","volume":"21","author":"Stricker","year":"1986","journal-title":"Am J Hematol"},{"key":"10.1038\/s41379-019-0325-6_bib23","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1182\/blood-2002-11-3343","article-title":"Clinical-cytogenetic associations in 306 patients with therapy-related myelodysplasia and myeloid leukemia: the University of Chicago series","volume":"102","author":"Smith","year":"2003","journal-title":"Blood"},{"key":"10.1038\/s41379-019-0325-6_bib24","doi-asserted-by":"crossref","first-page":"E80","DOI":"10.1002\/ajh.23966","article-title":"Characteristics and outcome of therapy-related myeloid neoplasms: Report from the Italian network on secondary leukemias","volume":"90","author":"Fianchi","year":"2015","journal-title":"Am J Hematol"},{"key":"10.1038\/s41379-019-0325-6_bib25","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1007\/s00277-018-3462-y","article-title":"A monocentric retrospective study of 138 therapy-related myeloid neoplasms","volume":"97","author":"Claerhout","year":"2018","journal-title":"Ann Hematol"},{"key":"10.1038\/s41379-019-0325-6_bib26","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1038\/nrc.2017.60","article-title":"Therapy-related myeloid neoplasms: when genetics and environment collide","volume":"17","author":"McNerney","year":"2017","journal-title":"Nat Rev Cancer"},{"key":"10.1038\/s41379-019-0325-6_bib27","series-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. revised","first-page":"153","article-title":"Therapy-related myeloid neoplasms","author":"Vardiman","year":"2017"},{"key":"10.1038\/s41379-019-0325-6_bib28","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1038\/sj.leu.2403187","article-title":"Karyotype is an independent prognostic parameter in therapy-related acute myeloid leukemia (t-AML): an analysis of 93 patients with t-AML in comparison to 1091 patients with de novo AML","volume":"18","author":"Schoch","year":"2003","journal-title":"Leukemia"},{"key":"10.1038\/s41379-019-0325-6_bib29","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1038\/nature13968","article-title":"Role of TP53 mutations in the origin and evolution of therapy-related acute myeloid leukaemia","volume":"518","author":"Wong","year":"2015","journal-title":"Nature"},{"key":"10.1038\/s41379-019-0325-6_bib30","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.leukres.2014.12.006","article-title":"Mutational profiling of therapy-related myelodysplastic syndromes and acute myeloid leukemia by next generation sequencing, a comparison with de novo diseases","volume":"39","author":"Ok","year":"2015","journal-title":"Leuk Res"},{"key":"10.1038\/s41379-019-0325-6_bib31","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.3324\/haematol.2013.098103","article-title":"p53 protein expression independently predicts outcome in patients with lower-risk myelodysplastic syndromes with del(5q)","volume":"99","author":"Saft","year":"2014","journal-title":"Haematologica"},{"key":"10.1038\/s41379-019-0325-6_bib32","doi-asserted-by":"crossref","first-page":"e320","DOI":"10.3324\/haematol.2016.143214","article-title":"Immunohistochemical pattern of p53 is a measure of TP53 mutation burden and adverse clinical outcome in myelodysplastic syndromes and secondary acute myeloid leukemia","volume":"101","author":"McGraw","year":"2016","journal-title":"Haematologica"},{"key":"10.1038\/s41379-019-0325-6_bib33","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1038\/nrclinonc.2015.105","article-title":"Inflammation and cancer: advances and new agents","volume":"12","author":"Crusz","year":"2015","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1038\/s41379-019-0325-6_bib34","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s10238-008-0153-3","article-title":"Sensitivity to cisplatin-induced mutations and elevated chromosomal aberrations in lymphocytes from sickle cell disease patients","volume":"8","author":"Alves","year":"2008","journal-title":"Clin Exp Med"},{"key":"10.1038\/s41379-019-0325-6_bib35","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/0165-2478(88)90178-2","article-title":"Is rapid proliferation in B centroblasts linked to somatic mutation in memory B cell clones?","volume":"18","author":"Zhang","year":"1988","journal-title":"Immunol Lett"}],"container-title":["Modern Pathology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41379-019-0325-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41379-019-0325-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395222009656?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395222009656?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41379-019-0325-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T00:42:53Z","timestamp":1760229773000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0893395222009656"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":35,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["S0893395222009656"],"URL":"https:\/\/doi.org\/10.1038\/s41379-019-0325-6","relation":{},"ISSN":["0893-3952"],"issn-type":[{"value":"0893-3952","type":"print"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Myeloid neoplasms in the setting of sickle cell disease: an intrinsic association with the underlying condition rather than a coincidence; report of 4 cases and review of the literature","name":"articletitle","label":"Article Title"},{"value":"Modern Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1038\/s41379-019-0325-6","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 United States & Canadian Academy of Pathology.","name":"copyright","label":"Copyright"}]}}